Profil
Ming Lun Tse currently works at Tian Ge Interactive Holdings Ltd., as Independent Non-Executive Director from 2022, Adlai Nortye Ltd., as Independent Non-Executive Director from 2021, and Association of Chartered Certified Accountants (Hong Kong), as Member from 2005.
Mr. Tse also formerly worked at Next Horizon Co. Ltd., as Senior Manager-Corporate Planning & Development from 2007 to 2009.
Mr. Tse received his undergraduate degree in 2002 from The University of Hong Kong.
Aktive Positionen von Ming Lun Tse
| Unternehmen | Position | Beginn |
|---|---|---|
| ADLAI NORTYE LTD. | Direktor/Vorstandsmitglied | 13.07.2021 |
| TIAN GE INTERACTIVE HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 18.08.2022 |
Association of Chartered Certified Accountants (Hong Kong) | Corporate Officer/Principal | 01.12.2005 |
Ehemalige bekannte Positionen von Ming Lun Tse
| Unternehmen | Position | Ende |
|---|---|---|
Next Horizon Co. Ltd.
Next Horizon Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business process outsourcing services | Corporate Officer/Principal | 01.08.2009 |
Ausbildung von Ming Lun Tse
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Hong Kong
University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Chartered Certified Accountants (Hong Kong) | |
Tian Ge Interactive Holdings Ltd.
Tian Ge Interactive Holdings Ltd. Information Technology ServicesTechnology Services Operates live social video communities | Technology Services |
Next Horizon Co. Ltd.
Next Horizon Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business process outsourcing services | Commercial Services |
Adlai Nortye Ltd.
Adlai Nortye Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biopharmaceuticals for cancer immunotherapy | Commercial Services |
















